Effects of Intravitreous Aflibercept Injection in Pachychoroid Neovasculopathy: Comparison with Typical Neovascular Age-Related Macular Degeneration

QR Code

Effects of Intravitreous Aflibercept Injection in Pachychoroid Neovasculopathy: Comparison with Typical Neovascular Age-Related Macular Degeneration

Sufian Elfandi,1 Sotaro Ooto,1 Manabu Miyata,1 Naoko Ueda-Arakawa,1 Yousif Subhi,1,2 Kenji Yamashiro,1 Hiroshi Tamura,1 Akio Oishi,1 Masayuki Hata,1 Nagahisa Yoshimura,1 Akitaka Tsujikawa1 1Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan; 2...

Full description

Saved in:

Bibliographic Details
Main Authors:	Elfandi S, Ooto S, Miyata M, Ueda-Arakawa N, Subhi Y, Yamashiro K, Tamura H, Oishi A, Hata M, Yoshimura N, Tsujikawa A
Format:	article
Language:	EN
Published:	Dove Medical Press 2021
Subjects:	age-related macular degeneration aflibercept pachychoroid neovasculopathy choroidal thickness Ophthalmology RE1-994
Online Access:	https://doaj.org/article/ac7dd9d24bb94dbd8081fca4bc60bb26
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Pachychoroid neovasculopathy in extramacular choroidal neovascularization
by: Gupta MP, et al.
Published: (2016)

Visual Outcome and Treatment Frequency of Anti-VEGF Therapy Using the Treat-and-Extend and Treatment Cessation Regimen for Exudative Age-Related Macular Degeneration and Pachychoroid Neovasculopathy
by: Kinoshita T, et al.
Published: (2021)

Intravitreal aflibercept versus bevacizumab for treatment of myopic choroidal neovascularization
by: Jia-Kang Wang, et al.
Published: (2018)

Intravitreal aflibercept for choroidal neovascularization associated with chorioretinitis: a pilot study
by: Korol AR, et al.
Published: (2017)

Intravitreal aflibercept for the treatment of choroidal neovascularization associated with pathologic myopia: a pilot study
by: Korol AR, et al.
Published: (2016)

Efficacy of intravitreal aflibercept injections for Japanese patients with polypoidal choroidal vasculopathy
by: Arakawa A, et al.
Published: (2017)

Aflibercept: a review of its use in the treatment of choroidal neovascularization due to age-related macular degeneration
by: Balaratnasingam C, et al.
Published: (2015)

Real-World Outcomes of Intravitreal Aflibercept for Neovascular Age-Related Macular Degeneration: A Large-Scale Postmarketing Surveillance in Korea
by: Ryu G, et al.
Published: (2021)

One-year outcome of intravitreal aflibercept injection for age-related macular degeneration resistant to ranibizumab: rapid morphologic recovery and subsequent visual improvement
by: Hirakata T, et al.
Published: (2016)

Short Axial Length Is Related to Asymmetric Vortex Veins in Central Serous Chorioretinopathy
by: Nobuhiro Terao, MD, PhD, et al.
Published: (2021)

Progression of Subclinical Pachychoroid Neovasculopathy to an Active Neovascularization in the Presence of Acquired Vitelliform Lesions
by: Manoj Soman, et al.
Published: (2021)

Vortex Vein Imaging: What Can It Tell Us?
by: Verma A, et al.
Published: (2021)

The implications of subretinal fluid in pachychoroid neovasculopathy
by: Geun Woo Lee, et al.
Published: (2021)

Intravitreal aflibercept for exudative age-related macular degeneration with good visual acuity: 2-year results of a prospective study
by: Sakamoto S, et al.
Published: (2018)

Two-year outcome of treat-and-extend aflibercept after ranibizumab in age-related macular degeneration and polypoidal choroidal vasculopathy patients
by: Azuma K, et al.
Published: (2018)

Switching to aflibercept among patients with treatment-resistant neovascular age-related macular degeneration: a systematic review with meta-analysis
by: Spooner K, et al.
Published: (2017)

Distinct Aqueous Humour Cytokine Profiles of Patients with Pachychoroid Neovasculopathy and Neovascular Age-related Macular Degeneration
by: Nobuhiro Terao, et al.
Published: (2018)

Twelve-week dosing with Aflibercept in the treatment of neovascular age-related macular degeneration
by: Garweg JG
Published: (2019)

Aflibercept treatment for neovascular AMD beyond the first year: consensus recommendations by a UK expert roundtable panel, 2017 update
by: Patel PJ, et al.
Published: (2017)

Worsening anatomic outcomes following aflibercept for neovascular age-related macular degeneration in eyes previously well controlled with ranibizumab
by: Nudleman E, et al.
Published: (2016)

Choroidal thickness after intravitreal ranibizumab injections for choroidal neovascularization
by: Ellabban AA, et al.
Published: (2012)

Chronic choriocapillaris ischemia in dilated vortex vein region in pachychoroid neovasculopathy
by: Hidetaka Matsumoto, et al.
Published: (2021)

Evaluation of contrast sensitivity and other visual function outcomes in neovascular age-related macular degeneration patients after treatment switch to aflibercept from ranibizumab
by: Nixon DR, et al.
Published: (2017)

Intravitreal aflibercept versus intravitreal ranibizumab for the treatment of diabetic macular edema
by: Fouda SM, et al.
Published: (2017)

Efficacy of Aflibercept versus Ranibizumab in the treatment of diabetic macular edema
by: Xiu-Xian Wang, et al.
Published: (2021)

Intravitreal ziv-aflibercept for macular edema following retinal vein occlusion
by: Paulose R, et al.
Published: (2016)

Results of switchback from ranibizumab to aflibercept in patients with exudative age-related macular degeneration
by: Koike N, et al.
Published: (2019)

One-Year Outcome of Aflibercept Intravitreal Injection in Vitrectomized Eyes with Diabetic Macular Edema
by: Tran THC, et al.
Published: (2021)

Intravitreal Ranibizumab or Aflibercept After Bevacizumab in Diabetic Macular Edema: Exploratory Retrospective Analysis
by: Pessoa B, et al.
Published: (2021)

Intravitreal Aflibercept versus Laser Photocoagulation in Asian Patients with Diabetic Macular Edema: The VIVID-East Study
by: Chen YX, et al.
Published: (2020)

Central Serous Chorioretinopathy in Elderly Patients Mimicking Occult Neovascular Age-Related Macular Degeneration
by: Adrean SD, et al.
Published: (2020)

Role of peripheral pan-retinal photocoagulation in diabetic macular edema treated with intravitreal ziv-aflibercept
by: Mansour AM, et al.
Published: (2019)

Idiopathic polypoidal choroidal vasculopathy in Thai patients with clinical and angiographic choroidal neovascularization
by: Bhoomibunchoo C, et al.
Published: (2017)

Vitreous Reflux Frequency and Intraocular Pressure After First-Time Intravitreal Aflibercept Injections: Comparison of 30- and 32-Gauge Needles
by: Muto T, et al.
Published: (2020)

Ranibizumab treatment history as predictor of the switch-response to aflibercept: evidence for drug tolerance
by: Dirani A, et al.
Published: (2018)

Factors Influencing Response to Aflibercept in Diabetic Macular Oedema Patients in a Diverse North West London Population: A Real-World Study
by: Sim SY, et al.
Published: (2021)

Analysis focusing on plasma von Willebrand factor in pachychoroid neovasculopathy and age-related macular degeneration
by: Hiromasa Hirai, et al.
Published: (2021)

Long-term outcome of intravitreal anti-vascular endothelial growth factor treatment for pachychoroid neovasculopathy
by: Jihyun Yoon, et al.
Published: (2021)

Short-term outcomes in patients with branch retinal vein occlusion who received intravitreal aflibercept with or without intravitreal ranibizumab
by: Sakanishi Y, et al.
Published: (2017)

Aflibercept versus Ranibizumab as a Second Line Therapy After Bevacizumab for Diabetic Macular Edema
by: Alsaedi NG, et al.
Published: (2021)